The Bernese-European RegistrY for ischemic stroke patients treated Outside current guidelines with Neurothrombectomy Devices using the SOLITAIRE™ FR With the Intention For Thrombectomy (BEYOND-SWIFT) is a retrospective, multi-center, non-randomized observational study aims to investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device (applied as initial devices used for intervention) in acute ischemic stroke patients who do not fulfill treatment eligibility according to current guidelines. Patients will be treated or were treated at the discretion of the investigator, independent of participation in this registry. Primary Analysis is the Impact of successful reperfusion on functional outcome at day 90 in patients presenting with large infarct cores (ASPECTS\<6) or minor symptoms (NIHSS\<8).
Study Type
OBSERVATIONAL
Enrollment
2,000
Defined as modified Thrombolysis in Cerebral Infarction 2b/3
Dept. of Neurology, Bern University Hospital
Bern, Switzerland
3 month functional independence
Number of patients with modified Rankin Scale \<=2
Time frame: 0-90 days
Favourable outcome
Number of patients with modified Rankin Scale \<=3
Time frame: 0-90 days
Excellent outcome
Number of patients with modified Rankin Scale \<=1
Time frame: 0-90 days
Successful reperfusion
Number of patients with modified Thrombolysis in Cerebral Infarction 2b / 3
Time frame: Day 0
Symptomatic intracranial hemorrhage
Number of patients with symptomatic intracranial hemorrhage according to ECASSII definition
Time frame: Day 0-1
Time to reperfusion
Groin puncture to TICI2b/3
Time frame: Day 0
Mortality
Number of patients with modified Rankin Scale 6
Time frame: Day 0-90
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.